Literature DB >> 12492582

Common expression of an unusual CD45 isoform on T cells from patients with large granular lymphocyte leukaemia and autoimmune lymphoproliferative syndrome.

Jack J H Bleesing1, John E Janik, Thomas A Fleisher.   

Abstract

Patients with T-cell large granular lymphocyte (T-LGL) leukaemia and autoimmune lymphoproliferative syndrome (ALPS) share many features, including autoimmunity and an expansion of (cytotoxic) T cells, which in ALPS patients express an unusual (B220) isoform of CD45, corresponding to an altered O-glycosylation profile. Here we showed that T-LGL leukaemia cells also expressed this B220 isoform. We hypothesize that B220+ T cells constitute proliferating T cells that have become competent to undergo apoptosis, but that constitutive (ALPS) or functional (T-LGL) defects prevent this process. Altered O-glycosylation of the extracellular domains of CD45 may have consequences for this tyrosine phosphatase as a regulator of cell proliferation and survival.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12492582     DOI: 10.1046/j.1365-2141.2003.04034.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  5 in total

Review 1.  [T-large granular lymphocyte leukaemia. An important differential diagnosis to Felty's syndrome].

Authors:  F Moosig; R Schoch; M Kneba
Journal:  Z Rheumatol       Date:  2006-09       Impact factor: 1.372

Review 2.  Diagnostic Tools for Inborn Errors of Human Immunity (Primary Immunodeficiencies and Immune Dysregulatory Diseases).

Authors:  Annely M Richardson; Ann M Moyer; Linda Hasadsri; Roshini S Abraham
Journal:  Curr Allergy Asthma Rep       Date:  2018-02-22       Impact factor: 4.806

3.  Developing an in vitro model of T cell type of large granular lymphocyte leukemia.

Authors:  Tong Ren; Jun Yang; Katie Broeg; Xin Liu; Thomas P Loughran; Hua Cheng
Journal:  Leuk Res       Date:  2013-10-14       Impact factor: 3.156

4.  Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of function.

Authors:  Jahnavi Aluri; Alicia Bach; Saara Kaviany; Luana Chiquetto Paracatu; Maleewan Kitcharoensakkul; Magdalena A Walkiewicz; Christopher D Putnam; Marwan Shinawi; Nermina Saucier; Elise M Rizzi; Michael T Harmon; Molly P Keppel; Michelle Ritter; Morgan Similuk; Elaine Kulm; Michael Joyce; Adriana A de Jesus; Raphaela Goldbach-Mansky; Yi-Shan Lee; Marina Cella; Peggy L Kendall; Mary C Dinauer; Jeffrey J Bednarski; Christina Bemrich-Stolz; Scott W Canna; Shirley M Abraham; Matthew M Demczko; Jonathan Powell; Stacie M Jones; Amy M Scurlock; Suk See De Ravin; Jack J Bleesing; James A Connelly; V Koneti Rao; Laura G Schuettpelz; Megan A Cooper
Journal:  Blood       Date:  2021-05-06       Impact factor: 25.476

Review 5.  Gain-of-function defects in toll-like receptor 8 shed light on the interface between immune system and bone marrow failure disorders.

Authors:  Jack Bleesing
Journal:  Front Immunol       Date:  2022-09-02       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.